149 related articles for article (PubMed ID: 12029443)
1. Cytotoxic efficacy of bendamustine in human leukemia and breast cancer cell lines.
Konstantinov SM; Kostovski A; Topashka-Ancheva M; Genova M; Berger MR
J Cancer Res Clin Oncol; 2002 May; 128(5):271-8. PubMed ID: 12029443
[TBL] [Abstract][Full Text] [Related]
2. In vitro induction of apoptosis of neoplastic cells in low-grade non-Hodgkin's lymphomas using combinations of established cytotoxic drugs with bendamustine.
Chow KU; Boehrer S; Geduldig K; Krapohl A; Hoelzer D; Mitrou PS; Weidmann E
Haematologica; 2001 May; 86(5):485-93. PubMed ID: 11410411
[TBL] [Abstract][Full Text] [Related]
3. Bendamustine is effective in p53-deficient B-cell neoplasms and requires oxidative stress and caspase-independent signaling.
Roué G; López-Guerra M; Milpied P; Pérez-Galán P; Villamor N; Montserrat E; Campo E; Colomer D
Clin Cancer Res; 2008 Nov; 14(21):6907-15. PubMed ID: 18980985
[TBL] [Abstract][Full Text] [Related]
4. In vitro evaluation of bendamustine induced apoptosis in B-chronic lymphocytic leukemia.
Schwänen C; Hecker T; Hübinger G; Wölfle M; Rittgen W; Bergmann L; Karakas T
Leukemia; 2002 Oct; 16(10):2096-105. PubMed ID: 12357363
[TBL] [Abstract][Full Text] [Related]
5. Poly ADP-ribose polymerase (PARP) inhibitors transiently protect leukemia cells from alkylating agent induced cell death by three different effects.
Pogrebniak A; Schemainda I; Pelka-Fleischer R; Nüssler V; Hasmann M
Eur J Med Res; 2003 Oct; 8(10):438-50. PubMed ID: 14594650
[TBL] [Abstract][Full Text] [Related]
6. Phenothiazines suppress proliferation and induce apoptosis in cultured leukemic cells without any influence on the viability of normal lymphocytes. Phenothiazines and leukemia.
Zhelev Z; Ohba H; Bakalova R; Hadjimitova V; Ishikawa M; Shinohara Y; Baba Y
Cancer Chemother Pharmacol; 2004 Mar; 53(3):267-75. PubMed ID: 14663628
[TBL] [Abstract][Full Text] [Related]
7. Bendamustine: something old, something new.
Tageja N; Nagi J
Cancer Chemother Pharmacol; 2010 Aug; 66(3):413-23. PubMed ID: 20376452
[TBL] [Abstract][Full Text] [Related]
8. Bendamustine (Treanda) displays a distinct pattern of cytotoxicity and unique mechanistic features compared with other alkylating agents.
Leoni LM; Bailey B; Reifert J; Bendall HH; Zeller RW; Corbeil J; Elliott G; Niemeyer CC
Clin Cancer Res; 2008 Jan; 14(1):309-17. PubMed ID: 18172283
[TBL] [Abstract][Full Text] [Related]
9. Antiproliferation effects of ponicidin on human myeloid leukemia cells in vitro.
Liu JJ; Huang RW; Lin DJ; Wu XY; Lin Q; Peng J; Pan X; Song YQ; Zhang MH; Hou M; Chen F
Oncol Rep; 2005 Apr; 13(4):653-7. PubMed ID: 15756438
[TBL] [Abstract][Full Text] [Related]
10. Selective tumor apoptosis by MF13, L-prolyl-L-m-[bis(chloroethyl)amino]-phenylalanyl-L-norvaline ethyl ester, a new sarcolysin containing tripeptide.
Roboz J; Jiang J; Holland JF; Bekesi JG
Cancer Res; 1997 Nov; 57(21):4795-802. PubMed ID: 9354441
[TBL] [Abstract][Full Text] [Related]
11. 3,3'-diindolylmethane and paclitaxel act synergistically to promote apoptosis in HER2/Neu human breast cancer cells.
McGuire KP; Ngoubilly N; Neavyn M; Lanza-Jacoby S
J Surg Res; 2006 May; 132(2):208-13. PubMed ID: 16580691
[TBL] [Abstract][Full Text] [Related]
12. Erythropoietin fails to interfere with the antiproliferative and cytotoxic effects of antitumor drugs.
Gewirtz DA; Di X; Walker TD; Sawyer ST
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2232-8. PubMed ID: 16609039
[TBL] [Abstract][Full Text] [Related]
13. Alkylphosphocholines: Effects on human leukemic cell lines and normal bone marrow cells.
Konstantinov SM; Topashka-Ancheva M; Benner A; Berger MR
Int J Cancer; 1998 Aug; 77(5):778-86. PubMed ID: 9688313
[TBL] [Abstract][Full Text] [Related]
14. Regression of brain metastases from breast carcinoma after chemotherapy with bendamustine.
Zulkowski K; Kath R; Semrau R; Merkle K; Höffken K
J Cancer Res Clin Oncol; 2002 Feb; 128(2):111-3. PubMed ID: 11862482
[TBL] [Abstract][Full Text] [Related]
15. Antineoplastic and anticlastogenic properties of curcumin.
Alaikov T; Konstantinov SM; Tzanova T; Dinev K; Topashka-Ancheva M; Berger MR
Ann N Y Acad Sci; 2007 Jan; 1095():355-70. PubMed ID: 17404048
[TBL] [Abstract][Full Text] [Related]
16. Bendamustine therapy in chronic lymphocytic leukemia.
Masiello D; Tulpule A
Expert Opin Pharmacother; 2009 Jul; 10(10):1687-98. PubMed ID: 19527193
[TBL] [Abstract][Full Text] [Related]
17. MZ3 induces apoptosis in human leukemia cells.
Fang L; He Q; Hu Y; Yang B
Cancer Chemother Pharmacol; 2007 Feb; 59(3):397-405. PubMed ID: 16900371
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptor gamma ligand troglitazone induces cell cycle arrest and apoptosis of hepatocellular carcinoma cell lines.
Yoshizawa K; Cioca DP; Kawa S; Tanaka E; Kiyosawa K
Cancer; 2002 Nov; 95(10):2243-51. PubMed ID: 12412180
[TBL] [Abstract][Full Text] [Related]
19. Bendamustine: rebirth of an old drug.
Cheson BD; Rummel MJ
J Clin Oncol; 2009 Mar; 27(9):1492-501. PubMed ID: 19224851
[TBL] [Abstract][Full Text] [Related]
20. Bendamustine in the treatment of chronic lymphocytic leukemia.
Knauf W
Expert Rev Anticancer Ther; 2009 Feb; 9(2):165-74. PubMed ID: 19192955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
